Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Xencor (XNCR) Stock Price & Analysis

374 Followers

XNCR Stock Chart & Stats

$35.03$4.39(14.33%)
At close: 4:00 PM EST
$20$25$30$35Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$30.86 - $35.05
52-Week Range
$10.38 - $35.05
Previous Close
$30.64
Volume
N/A
Average Volume (3M)
1.67M
Market Cap
$2.28B
Enterprise Value
$934.98M
Total Cash (Recent Filing)
$456.45M
Total Debt (Recent Filing)
$65.21M
Price to Earnings (P/E)
―
Beta
1.13
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

XmAb Platform

The XmAb platform provides a reusable antibody-engineering foundation across cancer and autoimmune or inflammatory programs. Its ability to enhance immune activity, half-life, and multispecific binding can support differentiated candidates and partnership opportunities over multiple development cycles.

XmAb819 Pipeline Progress

Encouraging Phase 1 activity and a defined proposed Phase 3 dose improve visibility for XmAb819, while planned FDA discussions and a randomized study create a potential path toward registration. Advancement would strengthen the pipeline and could expand future partnering or royalty opportunities.

Non-dilutive Capital

The settlement supplies substantial non-dilutive capital and restores management's stated runway through 2028, reducing near-term financing pressure. Retained ex-U.S. royalties also preserve an ongoing international revenue stream, supporting flexibility while clinical programs advance.

Bears Say

Persistent Losses

Sizable net losses and deeply negative operating results show that current development spending is not yet supported by recurring earnings. Continued losses can erode the capital base and leave future financial performance dependent on successful clinical progress, partnerships, or additional funding.

Ongoing Cash Burn

Persistent negative operating and free cash flow indicates the business remains far from self-funding. Even with the settlement-supported runway, continued cash consumption may require disciplined spending and could eventually increase reliance on milestone receipts, royalties, partnerships, or financing.

Revenue Volatility

A volatile revenue profile makes it difficult to establish dependable earnings power, particularly for a company relying on collaborations, licensing, milestones, and royalties. Uneven receipts can complicate planning and leave results exposed to the timing of partner-driven development and commercial events.

Xencor News

XNCR FAQ

What was Xencor’s price range in the past 12 months?
Xencor lowest stock price was $10.38 and its highest was $35.05 in the past 12 months.
What is Xencor’s market cap?
Xencor’s market cap is $2.28B.
When is Xencor’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Xencor’s earnings last quarter?
Xencor released its earnings results on Nov 09, 2026. The company reported $0.5 earnings per share for the quarter, beating the consensus estimate of -$0.334 by $0.834.
Is Xencor overvalued?
According to Wall Street analysts Xencor’s price is currently Undervalued.
Does Xencor pay dividends?
Xencor does not currently pay dividends.
What is Xencor’s EPS estimate?
Xencor’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xencor have?
Xencor has 74,353,390 shares outstanding.
What happened to Xencor’s price movement after its last earnings report?
Xencor reported an EPS of $0.5 in its last earnings report, beating expectations of -$0.334. Following the earnings report the stock price went up 0.806%.
Which hedge fund is a major shareholder of Xencor?
Hedge funds hold Xencor shares: the largest hedge-fund position in Xencor is 71,887,169 shares, and hedge funds increased their holdings by 843.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology